Related Experiment Video
Updated: Jul 22, 2026
08:59
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Evaluating lead bioavailability data by means of a physiologically based lead kinetic model
J Polák1, E J O'Flaherty, G B Freeman
1Department of Environmental Health, University of Cincinnati College of Medicine, Ohio 45267-0056, USA.
Summary
A new method using physiologically based kinetic modeling accurately estimates lead bioavailability by fitting blood and bone lead levels. This approach reveals dose-dependent fractional absorption that conventional methods miss.
Area of Science:
- Environmental Toxicology
- Pharmacokinetics
- Biomonitoring
Background:
- Lead exposure from various sources poses significant health risks.
- Accurate estimation of lead bioavailability is crucial for risk assessment.
- Traditional methods may not fully capture complex lead absorption dynamics.
Purpose of the Study:
- To develop and validate a physiologically based kinetic model for estimating lead bioavailability.
- To investigate the dose-dependent relationship between lead intake and fractional absorption.
- To compare the efficacy of the new modeling approach with conventional analyses.
Main Methods:
- Simultaneous fitting of a physiologically based kinetic model to blood and bone lead concentrations in rats.
- Optimization of fractional absorption as the sole variable.
- Application to data from rats exposed to dietary lead from lead acetate, contaminated soils, and mine waste.
Main Results:
- Fractional lead absorption decreased with increasing lead intake, demonstrating dose dependence.
- The magnitude of dose dependence varied significantly based on the lead source.
- The novel model identified dose-dependent absorption, which conventional methods failed to reveal.
Conclusions:
- Physiologically based kinetic modeling provides a more accurate estimation of lead bioavailability.
- Lead bioavailability is influenced by both the dose and the source of exposure.
- This modeling approach enhances the understanding of lead toxicokinetics and risk assessment.
Related Concept Videos
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
A recent model describes pravastatin's hepatobiliary excretion, mediated...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.